CAP-1002

( DrugBank: CAP-1002 / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
113	筋ジストロフィー	4

113. 筋ジストロフィー

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

trials per page:

Showing 1 to 4 of 4 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05126758 (ClinicalTrials.gov)	June 22, 2022	4/11/2021	A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of ...	Muscular Dystrophies;Muscular Dystrophy, Duchenne;Muscular Disorders, Atrophic;Muscular Diseases;Neu ...	Biological: CAP-1002;Drug: Placebo	Capricor Inc.	NULL	Recruiting	10 Years	N/A	Male	68	Phase 3	United States
2	NCT04428476 (ClinicalTrials.gov)	July 20, 2020	9/6/2020	Open-label Extension of the HOPE-2 Trial	Open-Label Extension of the HOPE-2 Duchenne Muscular Dystrophy Trial	Duchenne Muscular Dystrophy	Biological: CAP-1002	Capricor Inc.	NULL	Active, not recruiting	10 Years	N/A	All	13	Phase 2	United States
3	NCT03406780 (ClinicalTrials.gov)	March 4, 2018	15/1/2018	A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy	A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of ...	Muscular Dystrophies;Muscular Dystrophy, Duchenne;Muscular Disorders, Atrophic;Muscular Diseases;Neu ...	Biological: CAP-1002;Drug: Placebo	Capricor Inc.	NULL	Completed	10 Years	N/A	Male	18	Phase 2	United States
4	NCT02485938 (ClinicalTrials.gov)	January 2016	19/6/2015	HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)	A Randomized, Open-label Study of the Safety and Efficacy of Multi- Vessel Intracoronary Delivery of ...	Duchenne Muscular Dystrophy;Cardiomyopathy	Drug: Allogeneic Cardiosphere-Derived Cells (CAP-1002)	Capricor Inc.	NULL	Completed	12 Years	N/A	Male	25	Phase 1/Phase 2	United States

First Previous1Next Last